Form D · Biotechnology
Cybele Microbiome, Inc.
San Diego, CA · CIK 0001953909
Offering snapshot reported Mar 1, 2024 · SEC filing
- Reported sold
- $252K Offering amount: $500K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 1, 2024 | Initial | $252,000 | No comparison | 5 | SEC filing |
| Feb 9, 2023 | Initial | $877 | No comparison | 19 | SEC filing |
| Nov 16, 2022 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Nov 14, 2022 | Initial | $893,500 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506470
Source: Form D, filed Mar 1, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicole M. Scott | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3210 Merryfield Row
San Diego, CA, 92121
San Diego, CA, 92121